Streetbeat News

Stock Prices

HRB

H&R Block shares are trading higher following the announcement of their Q3 financial results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:23 pm

UI

Ubiquiti reported mixed Q3 financial results, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:23 pm

NNI

Nelnet shares surged following the announcement of better-than-expected Q1 adjusted EPS results, indicating a positive financial performance.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:22 pm

G

Genpact shares surged following the announcement of its Q1 financial results, which exceeded expectations. The company also increased its forecast for FY24 earnings per share (EPS) and provided Q2 revenue guidance that surpassed analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:22 pm

ARWR

Arrowhead Pharmaceuticals shares are trading lower following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:22 pm

EVH

Evolent Health's shares declined following the announcement of its Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:21 pm

OXY

Deep-pocketed investors have shown a bearish sentiment towards Occidental Petroleum (NYSE:OXY), with a notable shift in options activity. Benzinga's tracking revealed a mix of bullish and bearish positions, with a price target range from $57.5 to $70.0. The company's current trading volume is 639,622, with a slight price decrease of -0.16%, and an average analyst target price of $75.8. The options activity and analyst ratings suggest a cautious but potentially optimistic outlook for OXY.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 2:21 pm

DIOD

Diodes shares are trading lower following the announcement of worse-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:21 pm

TCNNF

Roth MKM analyst Scott Fortune has maintained a Buy rating on Trulieve Cannabis (OTC:TCNNF) and increased the price target from $16 to $19. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:18 pm

VCTR

Victory Capital's shares are trading lower following the announcement of mixed Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:18 pm